Benjamin Edwards Inc Astrazeneca PLC Transaction History

Benjamin Edwards Inc

$8.36 Billion
Q3 2025

A detailed history of Benjamin Edwards Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Benjamin Edwards Inc holds 65,572 shares of AZN stock, worth $5.46 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

65,572

Previous 64,635 1.45%

Holding current value

$5.46 Million

Previous $4.52 Million 11.38%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$68.72 - $82.11 $64,390 - $76,937	937 Added 1.45%	65,572 $5.03 Million
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $625,541 - $723,225	9,643 Added 17.54%	64,635 $4.52 Million
Q1 2025 May 12, 2025	SELL	$65.37 - $77.96 $70,795 - $84,430	-1,083 Reduced 1.93%	54,992 $4.04 Million
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $239,907 - $302,085	-3,796 Reduced 6.34%	56,075 $3.67 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $3.57 Million - $4.08 Million	46,537 Added 349.01%	59,871 $4.67 Million
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $102,486 - $123,993	-1,534 Reduced 10.32%	13,334 $1.04 Million
Q1 2024 Apr 29, 2024	BUY	$61.03 - $69.57 $61 - $69	1 Added 0.01%	14,868 $1.01 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $418,933 - $468,956	-6,769 Reduced 31.29%	14,867 $1 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $219,517 - $242,704	3,385 Added 18.55%	21,636 $1.47 Million
Q2 2023 Aug 15, 2023	BUY	$69.91 - $75.81 $23,909 - $25,927	342 Added 1.91%	18,251 $1.31 Million
Q1 2023 Apr 27, 2023	SELL	$63.15 - $71.6 $215,025 - $243,797	-3,405 Reduced 15.98%	17,909 $1.24 Million
Q4 2022 Feb 07, 2023	BUY	$54.21 - $70.44 $147,830 - $192,089	2,727 Added 14.67%	21,314 $1.45 Million
Q3 2022 Oct 28, 2022	BUY	$53.02 - $135.75 $98,511 - $252,223	1,858 Added 11.11%	18,587 $1.02 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $136,535 - $163,906	2,304 Added 15.97%	16,729 $1.11 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $354,434 - $426,950	6,361 Added 78.88%	14,425 $957,000
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $382,785 - $452,299	7,086 Added 724.54%	8,064 $470,000
Q3 2021 Nov 02, 2021	BUY	$55.56 - $60.79 $37,669 - $41,215	678 Added 226.0%	978 $59,000
Q1 2020 May 07, 2020	BUY	$37.79 - $51.33 $11,337 - $15,399	300 New	300 $13,000

Others Institutions Holding AZN

# of Institutions

1,442

Shares Held

498M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $258B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Astrazeneca PLC Transaction History